je.st
news
FDA approves 1st cheaper version of J&J's top drug Remicade
2016-04-06 02:53:09| Biotech - Topix.net
" Federal health officials have approved a cheaper version of Johnson & Johnson's blockbuster drug, Remicade, a pricey biotech medicine for inflammatory diseases. The approval of Inflectra Tuesday is only the second time that the Food and Drug Administration has approved a quasi-generic biotech drug for the U.S. market.
Tags: top
version
1st
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|